Dr. Reddy's Stock Updates and Market Performance Analysis November 2026
Dr. Reddy's Laboratories' stock performance is tracked with real-time updates showing recent prices around 1355 to 1370 INR, market capitalization near 113,000 to 115,000 crore INR, and a price-to-earnings ratio around 40.5. Earnings per share remain steady at 33.54. The coverage integrates fundamental and technical analysis, providing investors with detailed insights and recommendations to support informed financial decisions as of early November 2026.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (58/100). Lens Score 29/100.
Outlets measured: economictimes, economictimes. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (50–65/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
economictimes broke this story on 3 Nov, 06:42 am. Other outlets followed.
- 1